Literature DB >> 16061184

Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin.

Christopher R Vakoc1, Sean A Mandat, Benjamin A Olenchock, Gerd A Blobel.   

Abstract

Methylation of histones modulates chromatin structure and function. Whereas methylation of histone H3 on lysines 4, 36, and 79 has been linked with gene activation, methylation of H3 on lysines 9 and 27 and histone H4 on lysine 20 is associated with heterochromatin and some repressed genes within euchromatin. Here, we show that H3K9 di- and trimethylation occur in the transcribed region of active genes in mammalian chromatin. This modification is dynamic, as it increases during activation of transcription and is rapidly removed upon gene repression. Heterochromatin Protein 1gamma (HP1gamma), a protein containing a chromo-domain that recognizes H3K9 methylation, is also present in the transcribed region of all active genes examined. Both the presence of HP1gamma and H3K9 methylation are dependent upon elongation by RNA polymerase II. These findings demonstrate novel roles for H3K9 methylation and HP1gamma in transcription activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061184     DOI: 10.1016/j.molcel.2005.06.011

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  316 in total

1.  The JmjN domain of Jhd2 is important for its protein stability, and the plant homeodomain (PHD) finger mediates its chromatin association independent of H3K4 methylation.

Authors:  Fu Huang; Mahesh B Chandrasekharan; Yi-Chun Chen; Srividya Bhaskara; Scott W Hiebert; Zu-Wen Sun
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

Review 2.  Promoter-associated RNAs and promoter-targeted RNAs.

Authors:  Bing-Xue Yan; Jin-Xia Ma
Journal:  Cell Mol Life Sci       Date:  2012-03-14       Impact factor: 9.261

Review 3.  Chromatin landscape: methylation beyond transcription.

Authors:  Joshua C Black; Johnathan R Whetstine
Journal:  Epigenetics       Date:  2011-01-01       Impact factor: 4.528

4.  A modified "cross-talk" between histone H2B Lys-120 ubiquitination and H3 Lys-79 methylation.

Authors:  Agus Darwanto; Matthew P Curtis; Matthew Schrag; Wolff Kirsch; Peng Liu; Guoliang Xu; Jonathan W Neidigh; Kangling Zhang
Journal:  J Biol Chem       Date:  2010-05-03       Impact factor: 5.157

5.  Regulation of herpes simplex virus type 1 thymidine kinase gene expression by thyroid hormone receptor in cultured neuronal cells.

Authors:  Shao-Chung V Hsia; Rajeswara C Pinnoji; Gautam R Bedadala; James M Hill; Jayavardhana R Palem
Journal:  J Neurovirol       Date:  2010-02       Impact factor: 2.643

6.  MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output.

Authors:  Lihong Chen; Zhenyu Li; Aleksandra K Zwolinska; Matthew A Smith; Brittany Cross; John Koomen; Zhi-Min Yuan; Thomas Jenuwein; Jean-Christophe Marine; Kenneth L Wright; Jiandong Chen
Journal:  EMBO J       Date:  2010-06-29       Impact factor: 11.598

7.  High expression of ABCG2 induced by EZH2 disruption has pivotal roles in MDS pathogenesis.

Authors:  K C Kawabata; Y Hayashi; D Inoue; H Meguro; H Sakurai; T Fukuyama; Y Tanaka; S Asada; T Fukushima; R Nagase; R Takeda; Y Harada; J Kitaura; S Goyama; H Harada; H Aburatani; T Kitamura
Journal:  Leukemia       Date:  2017-07-19       Impact factor: 11.528

Review 8.  Epigenetics and T helper 1 differentiation.

Authors:  Thomas M Aune; Patrick L Collins; Shaojing Chang
Journal:  Immunology       Date:  2008-12-18       Impact factor: 7.397

9.  Epigenomic elements enriched in the promoters of autoimmunity susceptibility genes.

Authors:  Mikhail G Dozmorov; Jonathan D Wren; Marta E Alarcón-Riquelme
Journal:  Epigenetics       Date:  2013-11-08       Impact factor: 4.528

10.  Chromatin-remodeling factors mediate the balance of sense-antisense transcription at the FGF2 locus.

Authors:  Lori A McEachern; Paul R Murphy
Journal:  Mol Endocrinol       Date:  2014-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.